A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.
about
Propofol: a review of its role in pediatric anesthesia and sedationInsights from neuroenergetics into the interpretation of functional neuroimaging: an alternative empirical model for studying the brain's support of behaviorPharmacokinetics and pharmacodynamics of propofol in cancer patients undergoing major lung surgery.Population pharmacokinetic-pharmacodynamic modeling and dosing simulation of propofol maintenance anesthesia in severely obese adolescents.Pharmacokinetic-pharmacodynamic modelling in anaesthesia.Automation of anaesthesia: a review on multivariable control.Propofol Breath Monitoring as a Potential Tool to Improve the Prediction of Intraoperative Plasma Concentrations.Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits.Evaluation of the aepEX™ monitor of hypnotic depth in pediatric patients receiving propofol-remifentanil anesthesia.The influence of target concentration, equilibration rate constant (ke0 ) and pharmacokinetic model on the initial propofol dose delivered in effect-site target-controlled infusion.Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.Population pharmacokinetics and pharmacodynamics of propofol in morbidly obese patients.Pharmacokinetics and pharmacodynamics of dexmedetomidine-induced vasoconstriction in healthy volunteers.Pharmacokinetic/Pharmacodynamic Model of CW002, an Investigational Intermediate Neuromuscular Blocking Agent, in Healthy Volunteers.
P2860
Q26796361-703253D0-518D-4823-801A-AF7F995E0544Q27022283-56B3315E-7354-49C7-A644-7BB6E8F7C4A3Q35164864-8F536F72-78FF-4CF2-BADF-CE498ADDD758Q35893890-B458DFFE-2C07-4B16-BB8B-C729E0C690D0Q38164107-A8C05AB9-05D1-43BF-867A-E2EECDF5A534Q38222877-44C2CFE8-6D73-467B-9219-4643B2A2A88AQ38926866-EBE92A0B-0C6D-46CA-A54B-A6EF449D3739Q38944572-C55A191A-68C2-4BBF-8751-42F481D87F43Q45779159-8C91893E-4507-40BF-A04A-F01D26CA4CCDQ47614047-32846319-79B4-41E7-929B-D55C2D6154BBQ47742227-C17FE186-FA6C-4346-9BA3-9F6F7D6B17D6Q48224924-C272F514-ABA7-44A6-9BED-3A52CC0086C4Q52679295-BBD80837-14EB-4424-ACEB-AA490DA34093Q52679626-5C73AFDD-7E0B-4928-B237-F7D5876784C1
P2860
A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A two-compartment effect site ...... nt rates of propofol infusion.
@en
A two-compartment effect site ...... nt rates of propofol infusion.
@nl
type
label
A two-compartment effect site ...... nt rates of propofol infusion.
@en
A two-compartment effect site ...... nt rates of propofol infusion.
@nl
prefLabel
A two-compartment effect site ...... nt rates of propofol infusion.
@en
A two-compartment effect site ...... nt rates of propofol infusion.
@nl
P2093
P1476
A two-compartment effect site ...... ent rates of propofol infusion
@en
P2093
Ake Norberg
Marcus A Björnsson
Mats O Karlsson
Sigridur Kalman
P2860
P2888
P304
P356
10.1007/S10928-010-9157-1
P577
2010-04-23T00:00:00Z